Janney Montgomery Scott LLC Increases Stock Position in Humana Inc. $HUM

Key Points

• Janney Montgomery Scott LLC has increased its stock position in Humana Inc. by 259.6%, now holding 17,788 shares valued at approximately $4.35 million.
• Several hedge funds have also modified their stakes in Humana, with 92.38% of the stock owned by institutional investors.
• Humana recently declared a quarterly dividend of $0.885 per share, which will be paid on October 31st, representing an annualized yield of 1.2%.

Janney Montgomery Scott LLC increased its position in shares of Humana Inc. (NYSE:HUM - Free Report) by 259.6% during the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 17,788 shares of the insurance provider's stock after buying an additional 12,842 shares during the period. Janney Montgomery Scott LLC's holdings in Humana were worth $4,349,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in Humana by 16.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,136,538 shares of the insurance provider's stock valued at $300,728,000 after purchasing an additional 158,528 shares in the last quarter. Focus Partners Wealth lifted its holdings in Humana by 104.2% during the first quarter. Focus Partners Wealth now owns 6,429 shares of the insurance provider's stock valued at $1,701,000 after purchasing an additional 3,281 shares in the last quarter. Envestnet Asset Management Inc. lifted its holdings in Humana by 2.4% during the first quarter. Envestnet Asset Management Inc. now owns 125,684 shares of the insurance provider's stock valued at $33,256,000 after purchasing an additional 2,950 shares in the last quarter. Circle Wealth Management LLC purchased a new position in Humana during the first quarter valued at $425,000. Finally, Arizona State Retirement System lifted its holdings in Humana by 3.4% during the first quarter. Arizona State Retirement System now owns 35,337 shares of the insurance provider's stock valued at $9,350,000 after purchasing an additional 1,165 shares in the last quarter. 92.38% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on HUM shares. Weiss Ratings reaffirmed a "sell (d+)" rating on shares of Humana in a report on Saturday, September 27th. Royal Bank Of Canada raised their price target on shares of Humana from $283.00 to $322.00 and gave the stock an "outperform" rating in a research note on Thursday, August 21st. Sanford C. Bernstein raised their price target on shares of Humana from $269.00 to $341.00 and gave the stock an "outperform" rating in a research note on Friday, September 5th. Morgan Stanley decreased their price target on shares of Humana from $290.00 to $277.00 and set an "equal weight" rating on the stock in a research note on Thursday, July 31st. Finally, Robert W. Baird decreased their price target on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research note on Friday, July 25th. Seven analysts have rated the stock with a Buy rating, twelve have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $293.50.

Humana Price Performance

Humana stock opened at $295.26 on Wednesday. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The stock has a market cap of $35.51 billion, a P/E ratio of 22.66, a PEG ratio of 1.73 and a beta of 0.42. The company has a 50-day moving average price of $277.31 and a 200 day moving average price of $257.76. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69.

Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion for the quarter, compared to analyst estimates of $31.85 billion. During the same quarter in the prior year, the business earned $6.96 earnings per share. Humana's revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. Sell-side analysts anticipate that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be given a dividend of $0.885 per share. The ex-dividend date is Friday, September 26th. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.2%. Humana's dividend payout ratio (DPR) is currently 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.